Week in Review 3/29/21

MHC COVID-19 Treatment Guidelines Updated

MHC’s Treatment Considerations in Adults and Children with Laboratory Confirmed SARS-CoV-2 (COVID-19) has been updated on the management of Tocilizumab drug interactions with Apixaban and Rivaroxaban.

COVID-19 Treatment Guidelines

Inpatient J&J Janssen COVID-19 Vaccine Administration Pilot

• MMC has received 200 doses of the J&J Janssen COVID-19 vaccine to be given to inpatients prior to discharge.
• We have started a pilot program on several MMC units, which is expected to last 2 weeks.
• The J&J COVID-19 vaccine is a 1-dose vaccine, and cannot be interchanged with the mRNA vaccines.
• A pharmacy team will identify eligible patients based on the current MDHHS eligibility criteria and will work with nursing to administer vaccines as part of this pilot program.
• Learnings from this pilot, as well as vaccine availability, will determine the feasibility of expanding system wide.

Addressing COVID-19 Vaccine Hesitancy | Advice from Frontline Experts

We encourage providers and staff to watch the March 31 COVID-19 Provider Forum, where a panel of frontline physician experts discussed COVID-19 vaccine hesitancy in our community.

March 31 Provider Forum

Munson Med Talks podcast

Visitation Policy Updates

MHC changed its visitation policy effective Monday, 3.29.21.

MHC Visitation Restrictions

New Hologic Panther Set to Boost In-house COVID-19 Testing Capacity

• In addition to Cepheid and Abbott, MHC is launching a third in-house
  COVID-19 testing platform, Hologic Panther, at MMC on 4.5.21.
• We will begin to transition non pre-procedure COVID-19 testing (symptomatic and asymptomatic) from outside laboratories to Hologic Panther starting 4.5.21.
• Pre-procedure COVID-19 testing will continue to be sent to outside laboratories (Spectrum, MI Health).
• Hologic Panther has an approximate turnaround time of 24 hours.
• We will continue to monitor our testing supplies and capacity.

COVID-19 Testing

In-House COVID-19 Testing

Although testing has increased as a result of the current surge in local COVID cases, our in-house testing reagent supplies remain strong.

COVID-19 Testing

Updated Resources

MHC’s COVID-19 Collection Locations

21st Century Cures Act Goes Into Effect Apr. 5

The 21^st Century Cures Act is set to go into effect on April 5, 2021.

Cures Act Resources

Munson Med Talks Podcast

MHC has launched a new podcast for providers: “Munson Med Talks.” The latest episode features Drs. Mark Cannon, Joshua Meyerson, and Nick Torney and host Dr. Christine Nefcy speaking on COVID-19 vaccination hesitancy. The podcast is available on most main podcast platforms. To provide feedback and ideas for the podcast, or to become a guest on the show, contact Sam Lang.

Munson Med Talks podcast